Article info

Download PDFPDF

Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Authors

  • Priyanka B. Subrahmanyam Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine Stanford CA USA PubMed articlesGoogle scholar articles
  • Zhiwan Dong Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Daniel Gusenleitner Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Anita Giobbie-Hurder Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA Department of Biostatistics and Computational BiologyDana-Farber Cancer Institute Boston MA USA PubMed articlesGoogle scholar articles
  • Mariano Severgnini Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Jun Zhou Department of Medical OncologyDana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Michael Manos Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Lauren M. Eastman Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA PubMed articlesGoogle scholar articles
  • Holden T. Maecker Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine Stanford CA USA PubMed articlesGoogle scholar articles
  • F. Stephen Hodi Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA Department of Medical OncologyDana-Farber Cancer Institute and Harvard Medical School Boston MA USA Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School Boston MA USA Dana-Farber Cancer Institute 450 Brookline Avenue 02215 Boston MA USA PubMed articlesGoogle scholar articles
  1. j (617) 632-5053 stephen_hodi{at}dfci.harvard.edu
View Full Text

Citation

Subrahmanyam PB, Dong Z, Gusenleitner D, et al
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Publication history

  • Received December 20, 2017
  • Accepted February 16, 2018
  • First published March 6, 2018.
Online issue publication 
March 06, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.